You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
隴神戎發(300534.SZ):宣肺止嗽合劑仍有較大市場需求
格隆匯 07-27 11:49

格隆匯7月27日丨有投資者向隴神戎發(300534.SZ)提問:宣肺止嗽合劑銷售同比增長的原因是什麼,未來是否會受到影響,如何看待這個產品銷售前景?

隴神戎發回復:宣肺止嗽合劑主要用於治療呼吸道疾病所致咳嗽、咳痰等症狀,具有止咳化痰、潤肺補氣以及提高機體免疫力等作用。2022年底由於冬季呼吸道疾病高發,治療咳嗽的中成藥市場需求增加。宣肺止嗽合劑因具有止咳化痰,疏風宣肺的功效,臨牀療效顯著,受到市場廣泛認可,銷售同比大幅增長。

隨着人口老齡化和氣候因素,呼吸系統發病率逐年上升,咳嗽作為呼吸系統疾病最普遍的症狀之一,宣肺止嗽合劑仍有較大市場需求,甚至一度出現供不應求情況。宣肺止嗽合劑因其優秀的止咳功效和臨牀治療效果,獲得了醫療機構的臨牀患者的廣泛認可,具有較強的市場競爭力,市場空間巨大,銷售前景良好。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account